Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17483874rdf:typepubmed:Citationlld:pubmed
pubmed-article:17483874lifeskim:mentionsumls-concept:C0013203lld:lifeskim
pubmed-article:17483874lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:17483874lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:17483874lifeskim:mentionsumls-concept:C0301869lld:lifeskim
pubmed-article:17483874pubmed:issue4lld:pubmed
pubmed-article:17483874pubmed:dateCreated2007-6-15lld:pubmed
pubmed-article:17483874pubmed:abstractTextThe ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a major obstacle for successful anticancer therapy. One major mechanism of resistance involves cellular drug efflux by expression of P-glycoprotein (P-gp), a membrane transporter with a wide variety of substrates. Anthracyclines are especially prone to induction of resistance by the P-gp mechanism. P-gp mediated resistance is often confronted by use of P-gp inhibitors, synthesis of novel analogs, or conjugating drugs to macromolecular carriers in order to circumvent the efflux mechanism. In this report, the effect of free and Elastin-like polypeptide (ELP) bound doxorubicin (Dox) on the viability of sensitive (MES-SA and MCF-7) and multidrug resistant (MES-SA/Dx5 and NCI/ADR-RES) human carcinoma cells was studied in vitro. The resistant MES-SA/Dx5 cells demonstrated about 70 times higher resistance to free Dox than the sensitive MES-SA cells, and the NCI/ADR-RES cells were about 30 fold more resistant than the MCF-7 cells. However, the ELP-bound Dox was equally cytotoxic in both sensitive and resistant cell lines. The ELP-bound Dox was shown to accumulate in MES-SA/Dx5 cells, as opposed to free Dox, which was rapidly pumped out by the P-gp transporter. Since ELP is a thermally responsive carrier, the effect of hyperthermia on the cytotoxicity of the ELP-Dox conjugate was investigated. Both cytotoxicity and apoptosis were enhanced by hyperthermia in the Dox resistant cells. The results suggest that ELP-Dox conjugates may provide a means to thermally target solid tumors and to overcome drug resistance in cancer cells.lld:pubmed
pubmed-article:17483874pubmed:languageenglld:pubmed
pubmed-article:17483874pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17483874pubmed:citationSubsetIMlld:pubmed
pubmed-article:17483874pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17483874pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17483874pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17483874pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17483874pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17483874pubmed:statusMEDLINElld:pubmed
pubmed-article:17483874pubmed:monthAuglld:pubmed
pubmed-article:17483874pubmed:issn0167-6997lld:pubmed
pubmed-article:17483874pubmed:authorpubmed-author:PriebeWaldema...lld:pubmed
pubmed-article:17483874pubmed:authorpubmed-author:FoktIzabelaIlld:pubmed
pubmed-article:17483874pubmed:authorpubmed-author:RaucherDrazen...lld:pubmed
pubmed-article:17483874pubmed:authorpubmed-author:BidwellGene...lld:pubmed
pubmed-article:17483874pubmed:authorpubmed-author:DavisAisha...lld:pubmed
pubmed-article:17483874pubmed:issnTypePrintlld:pubmed
pubmed-article:17483874pubmed:volume25lld:pubmed
pubmed-article:17483874pubmed:ownerNLMlld:pubmed
pubmed-article:17483874pubmed:authorsCompleteYlld:pubmed
pubmed-article:17483874pubmed:pagination313-26lld:pubmed
pubmed-article:17483874pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:meshHeadingpubmed-meshheading:17483874...lld:pubmed
pubmed-article:17483874pubmed:year2007lld:pubmed
pubmed-article:17483874pubmed:articleTitleA thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.lld:pubmed
pubmed-article:17483874pubmed:affiliationDepartment of Biochemistry, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.lld:pubmed
pubmed-article:17483874pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17483874pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17483874lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17483874lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17483874lld:pubmed